[
  {
    "ts": "2025-09-17T14:00:00+00:00",
    "headline": "Mapi Pharma Announces First Patient Recruited in Phase-I/II Study of Cariprazine Depot Once Monthly Injection",
    "summary": "NESS ZIONA, Israel, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Mapi Pharma Ltd., a fully integrated, late-stage clinical development biopharmaceutical company focused on developing innovative long-acting depot injectable treatments, today provided an update on the clinical development program for its cariprazine once monthly injection. The company has enrolled the first patient into a Phase I/II study evaluating the product. Mapi Pharma’s injectable version of cariprazine, developed using its patented D",
    "url": "https://finance.yahoo.com/news/mapi-pharma-announces-first-patient-140000726.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "382d8c99-7276-3aa7-ade0-e52146baaea0",
      "content": {
        "id": "382d8c99-7276-3aa7-ade0-e52146baaea0",
        "contentType": "STORY",
        "title": "Mapi Pharma Announces First Patient Recruited in Phase-I/II Study of Cariprazine Depot Once Monthly Injection",
        "description": "",
        "summary": "NESS ZIONA, Israel, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Mapi Pharma Ltd., a fully integrated, late-stage clinical development biopharmaceutical company focused on developing innovative long-acting depot injectable treatments, today provided an update on the clinical development program for its cariprazine once monthly injection. The company has enrolled the first patient into a Phase I/II study evaluating the product. Mapi Pharma’s injectable version of cariprazine, developed using its patented D",
        "pubDate": "2025-09-17T14:00:00Z",
        "displayTime": "2025-09-17T14:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/b70c96d02ae0ada72c462adca7f1849b",
          "originalWidth": 887,
          "originalHeight": 447,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/bnl5lXd3cg._Pu3gP9zJtw--~B/aD00NDc7dz04ODc7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/b70c96d02ae0ada72c462adca7f1849b.cf.webp",
              "width": 887,
              "height": 447,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/2fWsn3TTG5.LwJKk1ve13w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/b70c96d02ae0ada72c462adca7f1849b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/mapi-pharma-announces-first-patient-140000726.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/mapi-pharma-announces-first-patient-140000726.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VTRS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]